Curis, Inc. (CRIS) is around the middle of the Biotechnology industry according to InvestorsObserver. CRIS received an overall rating of 38, which means that it scores higher than 38 percent of all stocks. Curis, Inc. also achieved a score of 35 in the Biotechnology industry, putting it above 35 percent of Biotechnology stocks. Biotechnology is ranked 52 out of the 148 industries.
CRIS has an Overall Score of 38. Find out what this means to you and get the rest of the rankings on CRIS!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Curis, Inc. Stock Today?
Curis, Inc. (CRIS) stock is down -15.45% while the S&P 500 has risen 0.2% as of 1:01 PM on Tuesday, Dec 13. CRIS is lower by -$0.10 from the previous closing price of $0.65 on volume of 3,712,020 shares. Over the past year the S&P 500 has fallen -14.35% while CRIS is lower by -88.15%. CRIS lost -$0.64 per share the over the last 12 months.
Click Here to get the full Stock Report for Curis, Inc. stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
